Karin E. de Visser - Concepedia

Author

Karin E. de Visser

Also Known As

K E de Visser, K E. de Visser, K de Visser, K. De Visser, K. E. de Visser, K. Visser, K. de Visser, K.E. De Visser, K.E. de Visser, Karin De Visser

204

Publications

19.7K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Leiden University Medical Center University of California, San Francisco Amsterdam UMC Location University of Amsterdam

About

Karin E. de Visser is an author at The Netherlands Cancer Institute specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	6.6K
2	Cell Biology	10	11	3.6K
3	Biology	3	3	122
4	Engineering	2	2	109
5	Natural Sciences	1	1	13

Karin E. de Visser

Publications

Citations

H-Index

Page 1

	Year	Citations
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal, Nature Breast Cancer MetastasisCancer ImmunosurveillanceLymphocyte DevelopmentImmune RegulationImmunology	2015	1.7K
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy Carola H. Ries, Michael A. Cannarile, Sabine Hoves, Cancer Cell Cancer TherapyTumor BiologyTumor-associated MacrophagesTumor ImmunologyCancer Immunosurveillance	2014	1.3K
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Nature Medicine Tumor ImmunologyBreast OncologyCancer ImmunosurveillancePd-1 BlockadeMedicine	2019	854
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent Karin E. de Visser, Lidiya Korets, Lisa M. Coussens Cancer Cell InflammationLymphoid NeoplasiaB Lymphocyte DependentLymphocyte DevelopmentImmunology	2005	802
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis Pauline Andreu, Magnus Johansson, Nesrine I. Affara, Cancer Cell InflammationMedicineImmunologyChronic InflammationFcrγ Activation	2010	565
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Max D. Wellenstein, Seth B. Coffelt, Danique E. M. Duits, Nature InflammationBreast Cancer MetastasisBreast OncologyMedicineImmunology	2019	484
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model Heather L. Greenstone, John D. Nieland, Karin E. de Visser, Proceedings of the National Academy of Sciences	1998	329
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer Sven Rottenberg, Anders O.H. Nygren, Marina Pajic, Proceedings of the National Academy of Sciences	2007	301
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner, Cancer Cell Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyImmune Checkpoint InhibitorAutoimmunity	2022	192
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response Camilla Salvagno, Metamia Ciampricotti, Sander Tuit, Nature Cell Biology InflammationCytokineMedicineImmunologyTumor Immunity	2019	160

Page 1